For Members Considering Intelligence

You have seen the free research. This is what the full system does.

Full valuations, a live-tracked model portfolio, and an AI analyst trained on all of it.


The Real Cost

The Cost of Getting It Wrong

Bad research does not announce itself. It arrives packaged in professional layouts, confident language, and consensus-aligned thinking. The cost is not the subscription fee. It is the capital you deploy on the back of analysis that was never rigorous enough to trust.

CSL CSL Limited (ASX: CSL)
Jul 2025 to May 2026
CSL Limited share price declining from approximately $250 to $100 between July 2025 and May 2026, with Alpha Insights valuation ratings overlaid at each coverage update.
Share price with Alpha Insights valuation ratings. Each marker is a published fair value estimate.

What the street recommended

Bloomberg's Analyst Recommendations screen for CSL. Green bars are Buy ratings. When sell ratings existed, the consensus target tracked the actual price. Once they vanished, the target drifted far above reality while the stock dropped 54%.

12-Month View
Bloomberg terminal: CSL analyst consensus over 12 months showing zero sell ratings while the share price declined from $250 to $100.
Full History
Bloomberg terminal: CSL analyst consensus over full history. Earlier periods with sell ratings show tighter price-target alignment.

Zero sell ratings across 20+ analysts. The consensus target sat above A$300 while the stock traded below A$110. No one on the street flagged the downside.

What our framework identified

Four coverage updates over nine months. Fair value consistently between A$110 and A$143. The rating only shifted to Attractive after the stock fell below our valuation range.

CSL CSL Limited
Aug 2025 to May 2026
Aug 2025 Strong Sell
Stock A$220
Fair Value A$110
Range A$94 to A$136
Downside -50%
Oct 2025 Unattractive
Stock A$176
Fair Value A$130
Range A$115 to A$145
Downside -26%
Feb 2026 Unattractive
Stock A$161
Fair Value A$132
Range A$100 to A$165
Downside -18%
May 2026 Attractive
Stock A$101
Fair Value A$143
Range A$104 to A$192
Upside +42%
Following street consensus on CSL
A$50,000 position at A$220, held through the decline
$50,000 $22,950
-$27,050 capital destroyed in nine months

CSL is not the only example.

Each of these was flagged as overvalued by our framework while the street maintained Buy ratings.

Ticker Signal Date Price Then Price Now Outcome
WTC Strong Sell Oct 2025 $88.30 $33.43 -62.1%
PME Sell Nov 2025 $263 $156.38 -40.5%
ZIP Sell Oct 2025 $4.72 $2.07 -56.1%
XRO Sell Oct 2025 $157.69 $57.85 -63.3%

One bad call is recoverable. A pattern of acting on conflicted or shallow research compounds into permanent capital impairment. The cost of wrong information is always higher than the cost of better information.


The Proof

Model Portfolio Performance

Top 15 long ideas, conviction-weighted (Half-Kelly). 14 October 2025 to 2 October 2026. Benchmark: S&P/ASX 200 (-2.4%).

+23.1% Cumulative Return
+25.5% Alpha vs ASX 200
1.32 Sharpe Ratio
2.10 Sortino Ratio
-11.6% Max Drawdown
+0.48 Beta

How the Record Is Built

PhasePeriodReturnASX 200
Long book, October signals14 Oct 2025 – 2 Mar 2026+13.0%+3.4%
Long book, February signals2 Mar – 10 Apr 2026+5.2%-2.6%
CORE model portfolio (live)10 Apr – 2 Oct 2026+3.6%-3.1%
March 2026 selloff (market -7.8%)whole month+3.6%-7.8%

One research process, re-tested every reporting season. From 10 April 2026 the record is the live CORE model portfolio; the earlier legs are the long book of the same signals, linked. It has outperformed in rising markets and in March's selloff alike.

Banked Winners (CORE, closed)

TickerRealised return
AMP+55%
CSL+48%
TWE+36%
RMS+31%
SDF+19%

Banked Misses (CORE, closed)

TickerRealised return
LYC-19%
WOR-17%
AGL-7%

Best Buy Calls — February to April 2026 Research Season

TickerCall datePrice thenOur fair valuePrice nowCall return
DGT12 Mar 2026$1.75$4.13$2.47+41.1%
RWC12 Mar 2026$2.92$4.07$4.74+62.3%
SDF15 Apr 2026$4.18$5.99$5.77+38.0%
WEB12 Mar 2026$2.75$6.36$3.39+23.3%
APA23 Feb 2026$8.86$14.37$10.67+20.4%

Best Sell Calls — Same Season

TickerCall datePrice thenOur fair valuePrice nowDecline captured
DRO27 Feb 2026$3.62$1.24$1.82+49.6%
LTR15 Apr 2026$1.90$0.35$0.80+58.2%
IPX15 Apr 2026$4.73$0.37$2.40+49.3%
SLX27 Feb 2026$6.90$1.59$4.17+39.6%
HUB22 Feb 2026$91.08$42.23$65.01+28.6%

The five best outcomes on each side from the February-April 2026 research season, using each company's latest valuation from that season, marked at the 2 October 2026 close (dividend-adjusted). SDF received a takeover bid within eight weeks of our A$5.99 valuation. Selection shows the best calls; across the season's 25 largest claimed-upside ideas, 15 rose (average move +7.2%), and of the 25 largest claimed-downside ideas, 11 fell (average -1.1%). The misses are in the tables above.

Ratings and positions are point-in-time. A company can be a sell at one price and a long at a lower one.

How alpha is generated: The framework does not rely on market timing. It holds the fifteen largest gaps between price and our fair value, conviction-weighted, and re-tests every position each reporting season. Positions are sold when price passes fair value, however well they are performing. March 2026 demonstrated the defensive side: the book gained +3.6% while the ASX 200 fell -7.8%. Since inception the record carries +25.5% alpha against a market that is down -2.4%.

All figures are model portfolio figures, gross of transaction costs and fees; net returns will be lower. Returns are computed from an indexed daily NAV, not actual trading accounts. From 10 April 2026 the record is the live CORE model portfolio (monthly review); from 14 October 2025 to 10 April 2026 it is the long book of the same research signals run in model form (linked record; initial sizing inverse-volatility, conviction-weighted thereafter). The record spans eleven and a half months. The selection universe was the ASX 100 to August 2026 and the ASX 200 from September 2026, defined as of March 2026 constituents. Past performance is not indicative of future results.


What You Get

What Intelligence Unlocks

Full Valuations & Forward Estimates

Complete intrinsic valuations with scenario-weighted probability analysis, forward earnings estimates, and explicit price targets for every company in coverage.

Scenario Analysis

Bull, base, and bear cases with explicit assumptions and probability weightings. Know what drives the upside and what triggers the downside before you commit capital.

Confidence Scoring

Every valuation carries a confidence assessment reflecting data quality, model reliability, and sector volatility. You always know how much weight to place on the output.

Updated Analysis & Commentary

Continuous coverage updates with revised outlooks, earnings commentary, and market positioning context as new data emerges each reporting season.


Your Research Assistant

Meet Alfie

Alfie is an AI research assistant built into the Alpha Insights portal. It draws from the full depth of every report we publish, using the same proprietary data the framework produces.

Ask about any company in our coverage. Get a valuation summary, understand the key drivers, or compare across sectors. Alfie does not generate generic AI summaries. It works from the same analytical foundation that drives the platform.

  • Ask about any of the 280+ ASX companies in coverage
  • Valuation breakdowns, key risks, and sector context on demand
  • Generates custom research briefs sent directly to your inbox
  • Built on proprietary Alpha Insights data, not public information summaries

What Members Say
"The depth of analysis is outstanding. Alpha Insights genuinely feels like having a buy-side analyst on call."
A
Aaron
ProductReview
"The more time I spend, the more I like it. A fantastic product."
PI
Self-Directed Investor
Former Business Consultant

Pricing

One Plan, Everything Included

Cancel anytime. No lock-in contracts.


Start Making Better Decisions

Questions? [email protected]